Efficacy of intrapartum chemoprophylaxis less than 4 hours duration

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 4, 2011, Pages 619-625

  Berardi, Alberto ^a   Rossi, Cecilia ^a   Biasini, Augusto ^b   Minniti, Simona ^c   Venturelli, Claudia ^c   Ferrari, Fabrizio ^c   Facchinetti, Fabio ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Terapia Intensiva Neonatale e Pediatrica   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

ampicillin; Group B streptococcus; infant; intrapartum chemoprophylaxis; sepsis

Indexed keywords

AMPICILLIN; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; COHORT ANALYSIS; DELIVERY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFANT; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS AGALACTIAE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LABOR, OBSTETRIC; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952430469     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.511347     Document Type: Article

References (18)

1. Edwards MS, Baker CJ. Group B Streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: Saunders; 2005. pp 1091-1156.
2. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
3. CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996; 45:1-24.
4. Benitz WE, Gould JB, DruzinML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77.
5. Davis RL, Hasselquist MB, Cardenas V, Zerr DM, Kramer J, Zavitkovsky A, Schuchat A. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol 2001;84:603-610. (Pubitemid 32234973)
6. RCOG. Guideline No. 36. Prevention of early onset neonatal group B streptococcal disease 2003;36:1-10. available at .
7. Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol 2006;108:1254-1265. (Pubitemid 44665425)
8. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999;104:203-209. (Pubitemid 29362124)
9. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP, Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-toinfant transmission. J Infect Dis 1983;148:810-816. (Pubitemid 14244266)
10. Lijoi D, Di Capua E, Ferrero S, Mistrangelo E, Giannattasio A, Morano S, Ragni N. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet 2007;275:373-379. (Pubitemid 46466372)
11. De Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91:112-114. (Pubitemid 28042344)
12. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics 1994;93:31-35.
13. Berardi A, Rossi K, Pizzi C, Baronciani D, Venturelli C, Ferrari F, Facchinetti F. Absence of neonatal streptococcal colonization after planned cesarean section. Acta Obstet Gynecol Scand 2006;85:1012-1013. (Pubitemid 44114966)
14. Smith D, Perry JD, Laine L, Galloway A, Gould FK. Comparison of BD GeneOhm real-time polymerase chain reaction with chromogenic and conventional culture methods for detection of group B Streptococcus in clinical samples. Diagn Microbiol Infect Dis 2008;61:369-372. (Pubitemid 351970641)
15. Berardi A, Lugli L, Baronciani D, Creti R, Rossi K, CicciaM, Gambini L, Mariani S, Papa I, Serra L, et al. Group B streptococcal infections in a Northern region of Italy. Pediatrics 2007;120:e487-e493. (Pubitemid 47358259)
16. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996;175:974-976. (Pubitemid 26357965)
17. Colombo DF, Lew JL, Pedersen CA, Johnson JR, Fan- Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus. Am J Obstet Gynecol 2006;194:466-470. (Pubitemid 43183702)
18. Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol 2008;112:265-270.